Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Birth Defects
Juno Diagnostics announces results of study using its noninvasive prenatal screening tests
By
LabPulse.com staff writers
The study examined the effectiveness of Juno Diagnostics’ Hazel NIPS test, which uses a sample-collection kit using capillary blood that may be self-collected by the patient.
April 3, 2023
Study suggests race adjustment unnecessary for alpha fetoprotein prenatal testing
By
Elissa Wolfson
Researchers recommend that a longstanding race-based adjustment to test-result values of alpha fetoprotein from a common prenatal screening should be discontinued.
February 6, 2023
Blood tests for concussion | Hidden Zika epidemic | Targeted prenatal genetic screening
By
Emily Hayes
Dear LabPulse Member,
August 26, 2019
Genomic analysis suggests Zika outbreaks are underreported
By
Emily Hayes
A large disease outbreak in Cuba in 2017 was caused by Zika, but it went unreported at the time, according to an analysis of travel patterns, mosquito modeling, and sequenced virus genomes taken from infected travelers, according to Yale School of Public Health epidemiologist Nathan Grubaugh, PhD, and colleagues (Cell, Vol. 178, pp. 1-15).
August 22, 2019
FDA's green light for InBios product signals arrival of Zika virus tests
By
Emily Hayes
InBios' ZIKV Detect 2.0 IgM Capture ELISA test was cleared through the agency's de novo premarket review pathway for low- to moderate-risk devices of a new type. In the future, similar tests will be reviewed through the 510(k) route, based on evidence of substantial equivalence.
May 23, 2019
Page 1 of 1